Jonathan Moss

USPTO Granted Patents = 15 (Patent Applications = 14)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 327(Granted Patents)

Company Filing History:

9 out of 920

The University of Chicago

patents

1 out of 349

Arch Development Corporation

4. 5 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10383869 - Treatment with opioid antagonists and mTOR inhibitors (2019-08-20),

2. 9717725 - Use of opioid antagonists (2017-08-01),

3. 9675602 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-06-13),

4. 9662390 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-05-30),

5. 9662325 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2017-05-30),

6. 9526723 - Treatment with opioid antagonists and mTOR inhibitors (2016-12-27),

7. 8685995 - Treatment with opioid antagonists and mTOR inhibitors (2014-04-01),

8. 8524731 - Use of opioid antagonists to attenuate endothelial cell proliferation and migration (2013-09-03),

9. 8518962 - Use of opioid antagonists (2013-08-27),

10. 6608075 - Use of methylnaltrexone and related compounds (2003-08-19),

11. 6559158 - Use of methylnaltrexone and related compounds to treat chronic opioid use side affects (2003-05-06),

12. 6399036 - Use of solid hydroxides as scavenging materials for cyanide gas (2002-06-04),

13. 6274591 - Use of methylnaltrexone and related compounds (2001-08-14),

14. 6126612 - Method for detecting cyanide in cutaneously transpired gas (2000-10-03),

15. 5972954 - Use of methylnaltrexone and related compounds (1999-10-26),

Title: Innovations and Contributions of Inventor Jonathan Moss

Introduction

Jonathan Moss is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of medical research. With a total of 15 patents to his name, he has made remarkable strides in developing treatments for various disorders characterized by cellular proliferation and migration.

Latest Patents

Among his latest patents, one notable invention focuses on the treatment of disorders using opioid antagonists and mTOR inhibitors. This invention provides methods for treating diseases characterized by cellular proliferation and migration by co-administering a synergistically effective amount of an mTOR inhibitor and a μ-opioid receptor antagonist. Another significant patent involves the use of opioid antagonists to attenuate cellular proliferation and migration, particularly in endothelial cells. This method aims to inhibit cancerous tumor growth and metastasis, utilizing peripherally restricted opioid antagonists.

Career Highlights

Jonathan has had a distinguished career, working at the University of Chicago, where he has contributed to groundbreaking research and innovation. His work has been instrumental in advancing medical treatments and understanding complex biological processes.

Collaborations

Throughout his career, Jonathan has collaborated with notable colleagues, including Patrick A Singleton and Chun-Su Yuan. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

In summary, Jonathan Moss is a dedicated inventor whose work has significantly influenced the medical field through his innovative patents and collaborations. His contributions continue to pave the way for advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.